Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: Major NKT cell recruitment and increased cytotoxicity

Scandinavian Journal of Immunology

Volumn 65, Issue 6, 2007, Pages 538-548

  Ananias, R Z ^a   Rodrigues, E G ^a   Braga, E G ^a   Squaiella, C C ^a   Mussalem, J S ^a   Longhini, A L F ^a   Travassos, L R ^a   Longo Maugeri I M ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; EFFECTOR CELL; FEMALE; HEAT TREATMENT; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; MELANOMA CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN PURIFICATION;

ANIMALS; ASCITIC FLUID; BIOLOGICAL RESPONSE MODIFIERS; CELL DEATH; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EXUDATES AND TRANSUDATES; FEMALE; IMMUNOPHENOTYPING; INJECTIONS, INTRAPERITONEAL; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; PROPIONIBACTERIUM ACNES; TUMOR CELLS, CULTURED;

EID: 34249325501     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01939.x     Document Type: Article

References (61)

1. Woodruff MFA, McBride WH, Dungar N. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum treated mice. Clin Exp Immunol 1974 17 : 509 18.
2. Halpern BN, Prévot R, Biozzi G et al. Stimulation de l'activité phagocytaire du système reticuloendothélial provoquée par Corynebacterium parvum. J Reticuloendothel Soc 1963 1 : 77 96.
3. Nussenzweig R. Increased nonspecific resistance to malaria produced by administration of killed Corynebacterium parvum. Exp Parasitol 1967 21 : 224 31.
4. Brener Z, Cardoso JE. Nonspecific resistance against Trypanosoma cruzi enhanced by Corynebacterium parvum. J Parasitol 1976 62 : 645 6.
5. Ha DKK, Lawton JWM, Gardner ID. The effect of in vitro modulation of macrophage activation on Mycobacterium lepraemurinum infection. J Comp Pathol 1986 96 : 565 73.
6. Hill JO. Modulation of the pattern of development of experimental disseminated Leishmaniasis by Corynebacterium parvum. J Leukoc Biol 1987 41 : 165 9.
7. Abath FGC, Coutinho EM, Montenegro SML, Gomes YM, Carvalho AB. The use of non-especific immunopotentiators in experimental Trypanosoma cruzi infection. Trans R Soc Trop Med Hyg 1988 82 : 73 6.
8. Teixeira KM, Coutinho EM, Abath FGC, Montenegro SML. Effects of non-specific immunopotentiators in experimental Schistosoma mansoni infection. II. Corynebacterium parvum. Rev Inst Med Trop São Paulo 1996 38 : 359 63.
9. Harima HA, Mendes NF, Mamizuka EM, Mariano M. Effects of glucan on murine Lupus evolution and on host resistence to Klebsiella pneumoniae. J Clin Lab Anal 1997 11 : 175 8.
10. Keller R, Keist R, Van Der Meide PH. Modulation of tumoricidal activity, induced in bone-marrow-derived mononuclear phagocytes by interferon-γ or Corynebacterium parvum, by interferon-β, tumor necrosis factor, prostaglandin E2, and transforming growth factor β. Inst J Cancer 1991 49 : 796 800.
11. Keller R, Keist R, Joller PW. Macrophage response to bacteria and bacterial products: modulation on Fcγ receptors and secretory and cellular activities. Immunology 1994 81 : 161 6.
12. Kennedy JD, Sutton RC, Conley FK. Efffect of intracerebrally injected Corynebacterium parvum on development and growth of metastatic brain tumor in mice. Neurosurgery 1989 25 : 709 14.
13. Halpern BN, Biozzi G, Stiffel C, Mouton D. Inhibition of tumour growth by administration of killed Corynebacterium parvum. Nature 1966 212 : 853 4.
14. Fisher B, Brown A, Wolmark N et al. Evaluation of the worth of Corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer. Cancer 1990 66 : 220 7.
15. Lipton A, Harvey HA, Balch CM, Antle CE, Heckard R, Bartolucci AA. Corynebacterium parvum versus bacille Calmete-Guérin adjuvant immunotherapy of stage II malignant melanoma. J Clin Oncol 1991 9 : 1151 6.
16. Green S, Dobrjansky MA, Chiasson MA, Carswell E, Schwartz MK, Old LJ. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst 1977 59 : 1519 22.
17. Warr GW, James K. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. Immunology 1975 28 : 431 42.
18. Megid J, Peracolli MT, Curi PR et al. Effect of vaccination and immunomodulators bacillus of 'Calmett-Guerin, avridine and Propionibacterium acnes' on rabies in mice. Comp Immunol Microbiol Infect Dis 1998 21 : 305 18.
19. Smith SR, Calzetta A, Bankowski J, Kenworthy BL, Terminelli C. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. J Leukoc Biol 1993 54 : 23 9.
20. Okamura H, Tsutsui H, Komatsu T et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995 378 : 88 91.
21. Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferon-γ inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol 1996 173 : 230 5.
22. Tsutsui H, Matsui K, Kawada N et al. IL-18 accounts for both TNF-alpha-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997 159 : 3961 7.
23. Matsui K, Yoshimoto T, Tsutsui H et al. Propionibacterium acnes treatment diminishes CD4+NK1.1+ T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 1997 159 : 97 106.
24. Tsuji H, Mukaida N, Harada A et al. Alleviation of lipopolysaccharide- induced acute liver injury in Propionibacterium acnes-primed INF-γ-deficient mice by a concomitant reduction of TNF-α, IL-12 and IL-18 production. J Immunol 1999 62 : 1049 55.
25. MacDonald AS, Straw AD, Bauman B, Pearce EJ. CD8-dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001 167 : 1982 8.
26. MacDonald AS, Straw AD, Dalton NM, Pearce EJ. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J Immunol 2002 168 : 537 40.
27. Cervi L, MacDonald AS, Kane C, Dzierszinski F, Pearce EJ. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004 172 : 2016 20.
28. Braga EG, Ananias RZ, Mussalem JS et al. Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice. Immunol Lett 2003 88 : 163 9.
29. Yoneyama H, Matsuno K, Zhang Y et al. Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med 2001 193 : 35 49.
30. Zhang Y, Yoneyama H, Wang Y. Mobilization of dendritic cell precursors into the circulation by administration of MIP 1-α in mice. J Natl Cancer Inst 2004 96 : 201 9.
31. Ichiyasu H, Matsukawa A, Iyonaga K, Mizobe T, Takahashi T, Ando M. Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits. J Leukoc Biol 1999 65 : 482 91.
32. Squaiella CC, Ananias RZ, Mussalem JS et al. In vitro and in vivo effect of killed Propionibacterium acnes and its purified soluble polyssacharide on mouse bone marrow stem cells and dendritic cell differentiation. Immunobiology 2006 211 : 105 16.
33. Longhini ALF, Mussalem JS, Takahashi H, Straus A, Longo-Maugéri IM. Soluble polysaccharide from Propionibacterium acnes with biological effects. Scand J Immunol 2001 54 (Suppl. 1 90.
34. Mussalem JS, Vasconcelos JRC, Squaiella CC et al. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene. Microbiol Immunol 2006 50 : 253 63.
35. Palmer JW, Gerlough TD. Scientific apparatus and laboratory methods. Science 1940 92 : 155 6.
36. Dawes J, Tuach SJ, Mcbride WH. Properties of an antigenic polysaccharide from Corynebacterium parvum. J Bacteriol 1974 20 : 24 30.
37. Tomecki J, Mara M. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells. Neoplasma 1987 34 : 15 22.
38. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 54.
39. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. A colorimetric method for the determination of sugars. Nature 1951 28 : 167.
40. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991 145 : 185 92.
41. Kruger T, Benke D, Eitner F et al. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol. 2004 15 : 613 21.
42. Engel D, Dobrindt U, Tittel A et al. Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect Immun 2006 74 : 6100 7.
43. Humphreys IR, Stewart GR, Turner DJ et al. A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect 2006 8 : 1339 46.
44. Serre K, Giraudo L, Siret C, Leserman L, Machy P. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo. Eur J Immunol 2006 36 : 1386 97.
45. Slifka MK, Pagarigan RR, Whitton JL. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 2000 164 : 2009 15.
46. Assarsson E, Kambayashi T, Sandberg JK et al. CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimularion in vitro and in vivo J Immunol 2000 165 : 3673 9.
47. Kim CH, Johnston B, Butcher EC. Trafficking machinery of NKT cells: shared ad differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity. Blood 2002 100 : 11 6.
48. Wu D, Xing GW, Poles MA et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A 2005 102 : 1351 6.
49. Stall AM, Wells SM, Lam KP. B1-cells: unique origins and functions. Immunology 1996 8 : 45 59.
50. Ghaffar A, Cullen RT, Woodruff MA. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum. Br J Cancer 1975 31 : 15 24.
51. Romics L Jr., Dolganiuc A, Velayudham A et al. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propionibacterium acnes. J Leukoc Biol 2005 78 : 1255 64.
52. Watanabe H, Miyaji C, Kawachi Y et al. Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ cells are present within a population of intermediate TCR cells. J Immunol 1995 155 : 2972 83.
53. Arase H, Arase N, Kobayashi Y, Nishimura Y, Yonehara S, Onoe K. Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 1994 180 : 423 32.
54. Tsutsui H, Nakanishi K, Matsui K et al. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996 157 : 3967 73.
55. Anzai R, Seki S, Ogasawara K et al. Interleukin-12 induces cytotoxic NK1+αβ T cells in the lungs of euthymic and athymic mice. Immunology 1996 88 : 82 9.
56. Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J Pathol 2003 199 : 275 88.
57. Rodrigues EG, Travassos LR. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gama anti-tumor cytotoxicity in vitro and in vivo. Cytokines Cell Mol Ther 2002 7 : 107 16.
58. Schreiber H. Tumor immunology. In : Paul WE ed. Fundamental Immunology, 5th edn. Philadelphia, PA : Williams L & Wilkins, 2003 : 1557 92.
59. Ding Y, Ma K, Tsui ZC. Induction of nitric oxide production by ganglioside GM3 in murine peritoneal macrophages activated for tumor cytotoxicity. In Vivo 1998 12 : 357 61.
60. Vila-Del Sol V, Diaz-Munoz MD, Fresno M. Requirement of tumor necrosis factor-α and nuclear factor-κB in the induction by IFN-γ of inducible nitric oxide synthase (iNOS) in macrophages. J Leukoc Biol 2007 81 : 272 83.
61. Zanardo RC, Costa E, Ferreira HH et al. Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils. Proc Natl Acad Sci U S A 1997 94 : 14111 4.